A Confirmatory Study of TAU-284 in Pediatric Patients With Atopic Dermatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

303

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
DermatitisAtopic
Interventions
DRUG

Bepotastine besilate

Two TAU-284 5mg tablets and one ketotifen fumarate dry syrup 1g placebo will be taken orally twice a day

DRUG

ketotifen fumarate

Two TAU-284 5 mg placebo tablets and one ketotifen fumarate dry syrup 1g will be taken orally twice a day

Trial Locations (1)

Unknown

Medical Corporation Kojinkai Asanuma Dermatology Clinic, Hokkaido

All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY